Using Medicare Advantage for the First Time in 2026? 3 Things You Need to Know.

Medicare Advantage plans commonly provide additional benefits (dental, vision, hearing) and an annual out-of-pocket limit but do not eliminate the obligation to pay the separate Part B premium. Enrollees face provider network restrictions that can produce high out-of-pocket costs if they go out of network, and there is an Advantage-only open enrollment window from Jan. 1 to Mar. 31 during which beneficiaries may make one change—either switch to a different Advantage plan or revert to Original Medicare and add a Part D drug plan. Investors should view this as consumer-policy information affecting healthcare plan choice and utilization rather than a market-moving event, with implications for payers and provider networks' patient flow and plan design competitiveness.

Analysis

Market structure: Medicare Advantage (MA) growth benefits managed-care insurers (UNH, HUM, ELV, CVS’s Aetna) by shifting spend into capitated, predictable cashflows and ancillary benefits that increase stickiness; hospitals and specialist practices (HCA, UHS) face margin pressure from narrower networks and prior-authorization flows. If MA penetration rises ~2–4 percentage points per year (recent historical range), payers gain pricing power on utilization management while outpatient/ambulatory providers see volume risk concentrated into lower-margin contracted rates.

Risk assessment: Key tail risks are regulatory (CMS rate reductions or stricter network/regulatory audits) and risk-adjustment clawbacks—either could compress EBITDA by 5–15% for exposed insurers within 6–12 months. Immediate risks (days–weeks) center on monthly enrollment signals and CMS rule notices (Nov–Apr cycle); medium-term (3–12 months) are earnings/MA margin disclosures; long-term (2–5 years) hinge on structural regulation and provider consolidation dynamics.

Trade implications: Favor overweighting large diversified payers with scale and Part D capabilities (UNH, HUM, CVS) for 6–18 months to capture enrollment tailwinds and ancillary cross-sell; underweight or hedge hospitals (HCA, UHS) that lack leverage with narrow-network plans. Use options to size risk: buy 6–9 month calls to capture upside while selling 1–3 month covered calls to harvest premium if volatility spikes around CMS announcements.

Contrarian angles: Consensus underprices regulatory vulnerability—if CMS proposes >3% net revenue cuts or tightens risk-adjustment rules, resets could be swift and large; conversely, market may be underestimating upside from accelerated MA enrollment in rural markets where incumbents cannot build narrow networks fast. Historical parallels (post-audit swings 2016–2018) show fast reversals in insurer multiples when CMS guidance changes, so size positions to tolerate 15–25% drawdowns.

Key Decisions for Investors

• Establish a 1.5–2.5% long position in UNH (UnitedHealth) and 1–1.5% in HUM (Humana) over the next 4–8 weeks, scaling in 25% tranches; target holding horizon 6–18 months to capture MA enrollment gains and Part D leverage.
• Initiate a 0.8–1.2% short or underweight exposure to HCA and UHS combined (hospital operators) as a hedge against narrower-network pressure; reduce if HCA/UHS trade >15% off current levels or announce successful network re-contracting.
• Implement an options collar: buy 6–9 month ATM calls on UNH/HUM equal to 50% of the equity notional and fund by selling 1–3 month OTM calls (30–40% delta) against existing holdings to limit cost while capturing near-term volatility around CMS notices.
• Run a pair trade: long CVS (1.0%) / short HCA (0.6%) to play pharmacy and managed-care integration benefiting from MA/Part D flows; monitor CVS PBM margins and reduce long if PBM revenue share falls >5% QoQ.
• Monitor CMS rulemaking and MA enrollment reports closely: if CMS proposes net revenue cuts >3% in the upcoming Annual Notice (expect Apr–Jun window), trim insurer longs by 40% within 3 trading days; if enrollment growth >3 p.p. year-over-year in Q1 reports, add 25–50% to positions within 2 weeks.